NEW YORK (GenomeWeb) – Advanced Biological Laboratories and the HIV Resistance Response Database Initiative (RDI) this week announced a collaboration on HIV management.

Under the agreement, data stored in ABL's health management system, TherapyEdge, can be automatically uploaded to RDI's HIV Treatment Response Prediction System (HIV-TRePS), allowing physicians to predict patient response to HIV drug combinations in seconds.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.